This trial is registered at ClinicalTrials.gov, NCT04241796, and is completed. Findings: Between Dec 12, 2019, and Dec 4, 2020, we recruited 6662 participants. 4204 (63·5%) of 6621 participants with analysable results were women, 2417 (36·5%) were men, and 6071 (91·7%...
000 participants – and what is believed to be the largest linked datasets of genomic and clinical data in the cancer field. GRAIL’s program includes the foundational CCGA development and validation study, the interventional PATHFINDER and PATHFINDER 2 studies,...
COMPass Pathways 专为iPad 设计 1.0 • 1 个评分 免费 截屏 iPad iPhone 简介 COMPASS myPathfinder supports patients throughout their psilocybin mental health therapy journey. PLEASE NOTE: myPathfinder is currently not available to everyone. Logging in to the app is restricted to clinical trial part...
EndoRobotics 11-Aug-2023 Early Stage VC Surgical Devices Pre-Clinical Trials You’re viewing 10 of 44 investments. Get the full list » Want detailed data on 3M+ companies? What you see here scratches the surface Request a free trial Want to dig into this profile? We’ll help you...
Clinical researchPhase I MORE ON THIS TOPIC Podcast New M&A Action, BMS’ Ongoing Cost Cuts and the Insatiable Demand for Weight Loss Drugs February 12, 2025 · 1 min read · Heather McKenzie Drug Development Bo...
Here, we present the end-of-trial results of pathfinder6, the first clinical trial to investigate the immunogenicity, efficacy, and safety of a PEGylated extended half-life FVIII replacement product in PUPs with severe hemophilia A. This analysis extends the treatment period as reported in the ...
GRAIL’s program includes the foundational CCGA development and validation study, the interventional PATHFINDER and PATHFINDER 2 studies, the NHS-Galleri randomized, controlled clinical study, the STRIVE and SUMMIT observational studies, and the REFLECTION real-world regi...
This study supports the feasibility of MCED screening for cancer and underscores the need for further research investigating the test's clinical utility. GRAIL.doi:10.1016/S0140-6736(23)01700-2Deb SchragTomasz M BeerCharles H McDonnellLincoln Nadauld...
COMPASS myPathfinder supports patients throughout their psilocybin mental health therapy journey. PLEASE NOTE: myPathfinder is currently not available to everyone. Logging in to the app is restricted to clinical trial participants. myPathfinder integrates with the Apple Health app to research clinical...
Primary care Adherence To Heart Failure guidelines IN Diagnosis, Evaluation and Routine management (PATHFINDER): a randomised controlled trial protocolHeart failurePRIMARY CAREClinical trialsIntroduction General practitioners (GPs) routinely provide care for patients with heart failure (HF); however, ...